According to a report of Yale University researchers published in the Journal Nature Genetics, that they have found the rare genetic variants that can be linked with an astonishing lower risk of developing high blood pressure in common population. The perception that this rare change in genetic material may collectively play a pivotal role in the development of general yet complicated diseases like Blood-pressure also has involvement in diagnosis and treatment of diseases like diabetes and schizophrenia.

Richard Lifton, chair of the Department of Genetics and Sterling Professor of Genetics and Internal Medicine at Yale, and Daniel Levy, director National Heart, Lung and Blood Institute’s Framingham Heart Study led that team of researchers.

The scientists examined DNA samples from 3,125 people who took part in the Framingham Heart Study, an epidemiology survey that led to a latent treasure of information about the causes of heart disease.

Read the rest of this entry